Experimental Manipulation of Sleep and Circadian Rhythms and the Role Played on Reward Function in Teens

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-15
SponsorUniversity of Pittsburgh

About this trial

Adolescence is a time of heightened reward sensitivity and greater impulsivity. On top of this, many teenagers experience chronic sleep deprivation and misalignment of their circadian rhythms due to biological shifts in their sleep/wake patterns paired with early school start times. Many studies find that this increases the risk for substance use (SU). However, what impact circadian rhythm and sleep disruption either together or independently have on the neuronal circuitry that controls reward and cognition, or if there are interventions that might help to modify these disruptions is unknown. Project 2 (P2) of the CARRS center will test an innovative and mechanistic model of brain circuitry that uses multi-method approaches, takes a developmental perspective, and incorporates key sleep and reward constructs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Typically enrolled in a traditional high-school with synchronous learning (in-person or online synchronous learning, but not cyber- or home-schooling) [school closures during the COVID-19 pandemic are an exception to this]

Physically and psychiatrically healthy

Provision of written informed consent and assent

Additional inclusion criterion for Experimental protocol: Meets operational definition of late sleep timing (>10:50PM habitual bedtime)

Disqualifiers

History of alcohol, cannabis, or illicit drug use in the past month, or greater than monthly use in the past year

Significant or unstable acute or chronic medical conditions

Frequent headaches or migraines

History of seizures

Trial design

Design model

Parallel

Treatments tested in this trial

  • Increase morning bright light

    Other intervention

    Participants will wear Re-Timer bright glasses for 30 minutes each morning upon rising

  • Decrease evening blue light

    Other intervention

    Participants will wear tinted glasses that block blue wavelength light for 2 hours before bed

  • Sleep Scheduling

    Behavioral

    Participants will advance their bedtime by 1.5 hours and regularize their wake time

  • Monitor sleep, mood, and substance use

    Behavioral

    Participants will complete smartphone-based sleep, mood, and substance use monitoring

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Advance/Extend ManipulationExperimental treatment 4 interventions
Group B: ControlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Weekday Sleep Duration--Actigraphy & Diaries

Total Sleep Time as determined by wrist actigraphy data \& sleep diaries (averaged across weekdays during 2 weeks at T1 and 2 weeks at T2)

Time frame
Baseline (2 Weeks), T2 (2 weeks)
2

Circadian Timing-Dim Light Melatonin Onset

Circadian Timing as determined by dim light melatonin onset during saliva sampling using the 4pg/ml threshold.

Time frame
Baseline Overnight Visit (T1) & T2 Overnight Visit(2 weeks later). Always on a Friday.
3

Circadian Alignment

Circadian alignment is operationalized as the interval between the dim light melatonin onset (DLMO) and sleep midpoint based on the prior two nights of actigraphy data.

Time frame
Baseline overnight (T1), T2 overnight (2 weeks after T1)
4

Reward motivation (Behavioral)

Assessed by adjusted average pumps on Balloon Analogue Risk Task, a computerized measure of risk taking behavior in which participants are presented with a series of balloons and offered the chance to earn money by pumping each balloon up by clicking a button. The adjusted average only includes non-burst trials.

Time frame
Baseline overnight (T1) vs. T2 overnight (2 weeks after T1)

Secondary outcomes

1

Cannabis use

Days of cannabis use on Timeline Follow Back interview administered during the baseline interview and in self-report surveys every 6 months.

Time frame
Continuously every 6 months for up to 5 years
2

Alcohol Use

Days of alcohol use on Timeline Follow Back interview administered during baseline interview and every six months via self-report

Time frame
Continuously every 6 months for up to 5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pittsburgh

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator